Introduction {#s1}
============

All living organisms are exposed to alkylating conditions caused by both endogenous (metabolites, ROS, free radicals, etc.) and exogenous (pollutants, chemoterapics, drugs, etc) species. Biological macromolecules including DNA, RNA, proteins and lipids are sensitive to electrophilic species permeating cellular defenses and then subjected to alkylation damages (Fu et al., [@B8]). Due to its long biological half-life, its presence in a single copy and its functional role, the DNA is the most sensitive target for methylation, which can have strong repercussions on cell survival (Jena, [@B10]). Methylating agents, like methyl methanesulphonate (MMS), comprise a major class of DNA-damaging compounds that occur both endogenously and in the environment (Lobo et al., [@B13]).

To counteract the effects of DNA alkylation, all organisms evolved multiple DNA repair strategies, which can either respond to the DNA lesions or rely on sensing of the alkylating agents. The occurrence of either event is recognized by specific regulators that activate transcription of several genes to provide a definite response (Volkert and Landini, [@B21]). In bacteria, fluctuating levels of environmental alkylating agents activate an inducible response that enhances cellular resistance to the same agents. This adaptive response has been studied most extensively in *Escherichia coli*, in which induced alkylation resistance results from increased expression of four genes, *ada, alkB, alkA*, and *aidB* (Landini and Volkert, [@B11]; Rippa et al., [@B16]).

Besides the induction of the Ada-related adaptative response, little is known on the global effect of methylation stress on *E. coli*, that greatly affects cells survival (Rippa et al., [@B17]). A comprehensive investigation of *E. coli* response to alkylating agents was then pursued in an attempt to identify the most affected cellular pathways. Differential proteomics experiments were designed to evaluate the changes in the proteomic profiles in the presence and in the absence of methylating molecules.

Quantitative proteomic data showed a large decrease in the expression of proteins involved in energy production pathways. However, the most intriguing result was the massive downregulation of the N-acetylneuraminate lyases NanA, an enzyme involved in sialic acid metabolism. Using different biological assays we demostrated that impairment of NanA expression greatly reduced biofilm formation and *E. coli* adhesion to HeLa cells. Moreover, inhibition of NanA activity by a synthetic drug strongly decreased adhesion and invasion to Caco-2 cells of the intestinal pathogen *E. coli* LF82 (AIEC). Our results suggest a possible role of *E. coli* lyase NanA in biofilm formation and in interaction with eukaryotic cells.

Methods {#s2}
=======

*E. coli* strains
-----------------

*E. coli* MV1161, a derivative of the standard laboratory strain AB1157, was used as reference strain in this work. Isogenic Δ*nanA::kan* mutant was constructed using the λ Red technique (Datsenko and Wanner, [@B7]). The MV1161 Δ*nanA::kan* mutant was transformed with pMAL-c5x-*nanA* plasmid containing the *nanA* gene in order to complement lyase activity. Both the Δ*nanA* mutant and the complement strain showed a growth rate superimposible with the parental strain. The strain LF82 (Boudeau et al., [@B2]), a prototype adherent-invasive *E. coli* (AIEC) strain, was used in adhesion and invasion experiments with Caco-2 eukaryotic cell line (<http://www.lgcstandards-atcc.org/products/all/HTB-37.aspx?geo_country=it>). LF82, was grown overnight in LB medium at 37°C, 180 rpm agitation, then used to inoculate 1:100 two different 250 mL flasks containing 100 mL of 22°C pre-warmed LB and underwent growth at 37°C, 180 rpm. Once reached an OD~600~ = 0.5, MMS was added to one flask at 0.04%, and OD~600~ measurements were taken every h from both flasks.

Differential in gel electrophoresis (DIGE)
------------------------------------------

DIGE experiments were performed on four biological replicates of MMS treated and four biological replicates of MMS untreated *E. coli* as previously described (Caterino et al., [@B4]). *E. coli* cells were homogenized in 0.5 ml of lysis buffer (7 M urea, 2 M thiourea, 4% chaps, 30 mM Tris-HCl pH 7.5) using a Dounce homogenizer. Concentration of the protein extracts was determined and equal amounts of protein lysates were then labeled *in vitro* using two different fluorescent cyanine minimal dyes (Cy3 and Cy5, respectively) differing in their excitation and emission wavelengths. A third cyanine dye (Cy2) was used to label a mixture of all samples as internal standard. The three differently labeled protein mixtures were pooled and subjected to isoelectric focusing on a 3--10 pH range with 24 cm strips using an IPGphor 2 (GE Healthcare) at 20°C (costant voltage 300 V for 3 h, voltage gradient to 1000 V in 6 h, voltage gradient to 8000 V in 3 h and costant voltage 8000 V for up to 4 h). The current limit was 50 mA/strip. The samples for the semipreparative gels were focused in a separate run using the same IEF condition. Following IEF, strips were equilibrated in 100 mM Tris, pH 8.0, 30% v/v glycerol, 2% w/v SDS, 6 M urea, reduced with 0.5% w/v DTT for 15 min and alkylated with 4.5% w/v iodoacetamide for further 15 min. IPG strips were then transferred to the top of a classical 12.5% SDS PAGE gel for a second orthogonal electrophoresis analysis. The SDS PAGE separation was performed at 2 W/gel, for 16 h at 25°C.

The Cy2, Cy3, and Cy5 images were obtained by scanning each of the four DIGE gels at excitation/emission wavelength of 480/530 nm for Cy2, 520/590 nm for Cy3 and 620/680 nm for Cy5 using a Typhoon 9410 TM scanner (GE Healthcare). The semi-preparative gel, prepared in an identical fashion, was scanned with 480/633 nm wavelengths. After consecutive excitation at both wavelengths, the images from the preparative gel were overlaid and subtracted (normalized) from the samples, whereby only differences (up or down expressed proteins) between the two samples were visualized. DeCyder software 5.01 (GE Healthcare) was used to compare the abundance changes between the control and treated samples. The Batch Processor Module (GE Healthcare) was used for normalization of the signals from each CyDye channel and spot detection on the 12 images from the four DIGE gels and the calculation of the volume ratio for each spot pair (Cy3:Cy2 and Cy5:Cy2 ratios). The Biological Variation.

Analysis (BVA) module (GE Healthcare) was used to match all the 12 spot maps from the four DIGE gels and calculate the average abundance changes and paired Student\'s *t*-test *p*-values for the variance of these ratios for each protein pair across all four samples.

By performing a high resolution image analysis on the four biological replicates, it was possible to visualize significant differences between numerous protein spots present on the gels. Differential spots were defined as having a variation higher than 1.2 (*p* \< 0.05) per previously established methods (Cella et al., [@B5]). The gels showed a high degree of similarity, with more than 80% of all spots superimposeable. The remaining 20% showed variation and were further studied.

Proteomic analysis
------------------

The spots of interest were excised, hydrolyzed and the peptide mixtures analyzed by MALDI-MS and LC-MSMS mass spectrometry, on a 4800 Plus MALDI TOF/TOF™ (Applied Biosystems, Framingham, MA, USA) and a LC/MSD Trap XCT Ultra (Agilent Technologies, Palo Alto, CA) equipped with a 1100 HPLC system and a chip cube (Agilent Technologies) respectively. MALDI spectra were acquired in the positive ion reflector mode using delayed extraction in the 800--4000 Da mass range. LC-MS/MS analysis was performed using data-dependent acquisition of one MS scan followed by MS/MS scans of the three most abundant ions in each MS scan. Raw data analyses were converted into a Mascot format text to identify proteins using Matrix Science software. The protein search considered the following parameters: non-redundant protein sequence database (NCBInr), specificity of the proteolytic enzyme used for the hydrolysis (trypsin), taxonomic category of the sample, up to one missed cleavage, cysteines as S-carbamidomethylcysteines, unmodified N- and C-terminal ends, methionines both unmodified and oxidized, putative pyro-Glu formation by Gln, precursor peptide maximum mass tolerance of 200 ppm, and a maximum fragment mass tolerance of 200 ppm.

Identified proteins were investigated to predict functional protein association networks for each entry using the STRING online database (<http://string-db.org>). Proteins were analyzed with the STRING software.

RNA extraction, reverse transcription and real-time PCR
-------------------------------------------------------

Three *E. coli* culture replicates were grown at 37°C in the presence and in the absence of 0.04% MMS according to proteomics experiments. In order to obtain an immediate stabilization of RNA, two volumes of RNA protect Bacteria Reagent (Qiagen) were added directly to one volume of bacterial culture (10 OD600 nm). Bacterial cells were harvested and each pellet was stored at -20°C overnight. Total RNA was extracted from culture using RNasy Midi Kit (Qiagen) according to the manufacturer\'s instructions. The purity and integrity of total RNA was verified by both 1% denatured agarose electrophoresis and by evaluating that the A260/A280 absorbance ratio was within the range 2.1--2.3.

Total RNA (1 μg) was reverse transcribed in 40 μL final reaction volume using TaqMan Universal PCR Master Mix kit (Applied Biosystem) according to the manufacturer\'s instructions. The cDNA was synthesized at 48°C for 60 min and then stored at −20°C. Real-time PCR primer sequences were designed using Primer Express 3.0 software. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed using SYBR green PCR Master Mix and Step ONE Real Time PCR System (Applied Biosystems) according to the manufacturer\'s instructions to measure *nanA* gene expression. *rpoA* amplifications were used as normalization controls. Each sample was analyzed three times to obtain average data. Relative transcript levels were calculated using the 2^−ΔΔCt^ formula (Ct = threshold cycle; Livak and Schmittgen, [@B12]).

Production of recombinant NanA protein and polyclonal anti NanA antibodies
--------------------------------------------------------------------------

*E. coli* MV1161 was amplified from host DNA by polymerase chain reaction (PCR) using the following primers: FW AGC[GGATCC]{.ul}ATGGCAACGAATTT; RW AAT[AAGCTT]{.ul}TCACCCGCGCTCTT, where the recognition sites for BamHI and HindIII are underlined. To obtain the *nanA* gene, the PCR product was digested with the appropriate restriction enzyme and cloned into the BamHI and HindIII sites of the pET28a vector. The resulting plasmid contained the coding sequence for the recombinant NanA protein fused to a 6-histidine tag to facilitate protein purification.

The recombinant gene was expressed into the *E. coli* strain BL21. Cells were grown in LB medium at 37°C with 50 μg/mL kanamicin to an optical density of \~0.5 at 600 nm, and 0.1 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) was added. The culture was grown for 3 h at 37°C for NanA production. Cells were harvested by centrifugation at 5000 rpm for 15 min at 4°C. The cellular pellet was resuspended in equilibration buffer (20 mM Na~2~HPO~4~, pH 7.4, 500 mM NaCl, 20 mM imidazole) containing 1 mM PMSF and disrupted by passage through a French Press.

The cell extract was centrifuged at 13000 rpm for 20 min at 4°C, to remove cell debris and the supernatant was filtered with a syringe-driven filter (0.22 μm) before protein purification. Soluble cell extract was loaded onto a His-Select Nickel Affinity Gel equilibrated with equilibration buffer and the bound protein was eluted with 500 mM imidazole in 50 mM phosphate buffer pH 7.4, 500 mM NaCl.

Protein concentration was estimated with Bradford reagent (Bio-Rad protein assay), protein purity was assessed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and its primary structure verified by MALDI mapping strategy. Purified NanA protein was used to produce antiNanA antibodies by rabbit immunization (PRIMM, Milano, Italy).

Western blot
------------

*E. coli* cultures were grown at 37°C in the presence and in the absence of 0.04% MMS according to proteomics experiments. The cell pellets were lysed by French Press, resolved on a 12.5% SDS-PAGE gel and transferred onto a PVDF membrane. The membrane was blocked with 3% v/v milk in PBS buffer at room temperature for 1 h. The immunodetection was conducted by incubating the membrane with the anti-NanA antibodies (1:300, Primm, Milano Italy) for 18 h at 4° C under slow stirring. The membrane was then incubated with the secondary antibody conjugated to horseradish peroxidase (1:50000) for 1 h. Target proteins were visualized by ECL detection (Pierce).

Static biofilm assays
---------------------

A quantity of 2 mL of overnight bacterial cultures grown in LB + 1% glucose was added into 6-well flat bottomed polystyrene plate (Falcon). The plates were incubated at 37°C in aerobic conditions in the presence of 0.04% MMS. Growth was monitored by measuring the OD600, and after 24 h incubation the ability of the *E. coli* strain to adhere to the polystyrene plates was tested. The liquid medium was removed and the wells washed with sterile distilled water. The plates were then stained with 0.1% crystal violet for 20 min (O\'Toole, [@B15]). Excess stain was rinsed off by placing the plate under running tap water. After the plates were air dried, the dye bound to the adherent cells was solubilized with 20% (v/v) glacial acetic acid and 80% (v/v) ethanol per well. The OD of each well was measured at 590 nm.

Biofilm assays on the complemented null NanA mutant strain were performed in the same conditions described above in the presence of 0.1 mM IPTG. Biofilm formation in the presence of a synthetic inhibitor was carried out on *E. coli* MV1161 strain grown in sterile 6-well flat-bottomed polystyrene plates treated with different concentrations of N-Acetyl-2,3-dehydro-2-deoxyneuraminic acid (DANA) ranging from 1 to 100 μg/mL. The plates were incubated aerobically at 37°C for 24 h and biofilm production was quantified as previously described.

Invasion and adhesion assays on HeLa and Caco-2 eukaryotic cell lines
---------------------------------------------------------------------

Bacteria from 18 h cultures in BHI broth, grown in the absence of MMS were further subcultured up to OD600 of 0.5 at 37°C with or without MMS 0.04%. HeLa cells, cultured in 24-well plates to obtain semi-confluent monolayers (1 × 10^5^ cells/well), were infected with 0.05 mL of logarithmically grown bacteria for 1 h at 37°C.

For the invasion assay, the monolayers were washed with PBS and treated with 0.5 mL of fresh medium containing 200 mg/mL of gentamicin for 1 h at 37°C to kill extracellular bacteria. Cells were then lysed by the addition of 0.025% Triton X-100 and plated on LB to count viable intracellular bacteria (Artini et al., [@B1]).

For the adhesion assay, loosely bound bacteria were removed from the cell monolayers by two washes with PBS. Cells were then lysed with 0.025% Triton X-100 and plated on LB agar to determine viable adherent bacteria. Adhesion efficiency was expressed as the percentage of the inoculated bacteria that adhered to HeLa cells.

Caco-2 intestinal cells were used for invasion and adhesion assays with AIEC LF82 strain (Darfeuille-Michaud et al., [@B6]). Caco-2 cells were seeded in a 12-well plate at a density of 4 × 10^5^ cells/well, let stand for 1 day, and medium (DMEM with low glucose supplemented with 10% FBS) replaced the day of infection. One mL of a 6 h-old LF82 culture (logarithmic phase) was harvested, and MMS at 0.04% was added for 20 min in one tube, while another was left non-treated as a control. After the induction step, both tubes were centrifuged at 3000 rpm for 5 min, and bacterial pellets resuspended in PBS. 10 μL of resuspended pellets were added to each well to obtain a MOI of bacteria/cells 10:1, and 12-well plates were incubated for 4 h at 37°C, 5% of CO~2~.

For the invasion assay, cells were washed three times with PBS and 2 mL of 22°C pre-warmed culture medium supplemented with 400 μg/mL of gentamicin were added to each well and the plate was incubated for 2 h at 37°C, 5% of CO~2~. Gentamicin was then removed washing three times with PBS and 1 mL of 1% Triton X-100 was added for 5 min during which the plates were gently swirled three times. Serial dilutions in PBS were performed till 10^−6^ and 100 μL of each dilution were plated onto TSA petri dishes (repeated three times). Colony-forming units (CFU) per mL were enumerated and the invasion index was expressed as the number of invasive bacteria per single Caco-2 cell.

For the adhesion assay, cells were washed three times with PBS and 1 mL of 1% Triton X-100 was added for 5 min, during which the plates were gently swirled three times. This concentration of Triton X-100 had no effect on bacterial viability for at least 30 min. Serial dilutions in PBS were performed till 10^−6^ and 100 μL of each dilution were plated onto TSA petri dishes (repeated three times). Colony-forming units (CFU) per mL were enumerated and the adhesion index was expressed as the number of adhesive bacteria per single Caco-2 cell.

Three biological replicates of both the invasion and adhesion assays were performed and the results expressed as mean ± standard error of the mean.

Results {#s3}
=======

DIGE experiments
----------------

Differential in Gel Electrophoresis (DIGE) was used to examine the global effect of methylation stress on *E. coli*. Bacterial cells were grown in four replicates and each culture was divided into two aliquots, one of them was treated with 0.04% MMS and the other one was kept untreated and used as control. Protein lysates from MMS treated and untreated cells were extracted and fractionated by bidimensional electrophoresis using a 3--10 pH gradient. The relative quantitative analysis was performed so that only proteins up or down expressed in all four treated cell samples versus control were considered (Figure [1A](#F1){ref-type="fig"}). The corresponding preparative gel is reported in Figure [1B](#F1){ref-type="fig"}, where differently expressed proteins in the presence of MMS are labeled and were submitted to the identification procedure.

![**Differential proteomic analysis of MMS treated MV1161 *E. coli*. (A)** Differential in Gel Electrophoresis (DIGE) of protein extracts from MV1161 *E. coli* in the absence and in the presence of MMS. Superimposed images of the individual fluorescent scans of analytical gels for the four analyzed biological replicates. **(B)** Semi-Preparative 2D-Gel Electrophoresis of protein extracts from MV1161 *E. coli*. The differentially expressed proteins in the presence of MMS submitted to mass spectrometric identification are labeled. **(C)** The network distribution of the 61 differentially expressed proteins according to STRING software. The top-ranked networks were in Metabolic Pathways, Glycolysis/Gluconeogenesis. Stronger associations are represented by thicker lines.](fmicb-07-00147-g0001){#F1}

The spots of interest were picked, *in situ* hydrolyzed with trypsin and the resulting peptide mixtures analyzed by LC-MS/MS. Proteins were identified using the Mascot software. A total of 69 differentially expressed proteins were identified in MMS treated *E. coli* cells compared to controls, 61 down and 8 up expressed, and are reported in Table [1](#T1){ref-type="table"}. Details of mass spectrometry analysis were reported in Table [1S](#SM2){ref-type="supplementary-material"} of Supplemental Materials.

###### 

**Differentially expressed proteins**.

  **2^x^**                                           **n SPOT**   ***p*-value**   **Protein description**                                                                     **Gene symbol**   **Swiss prot**
  -------------------------------------------------- ------------ --------------- ------------------------------------------------------------------------------------------- ----------------- ------------------
  **METABOLIC PATHWAYS**                                                                                                                                                                        
  −2.76                                              1545         0.0018          Transketolase 2                                                                             tktB              [P33570](P33570)
  −1.82                                              1530         0.0049          Fumarate reductase flavoprotein subunit                                                     frdA              [P00363](P00363)
  −1.73                                              2441         0.0042          Bifunctional protein GlmU                                                                   glmU              [P0ACC7](P0ACC7)
  −1.67                                              3025         0.0023          Dihydroorotase                                                                              pyrC              [P05020](P05020)
  −1.62                                              3317         0.0068          Cytidine deaminase                                                                          cdd               [P0ABF6](P0ABF6)
  −1.62                                              2006         0.0032          Fumarate hydratase class I, anaerobic                                                       fumB              [P14407](P14407)
  −1.56                                              2314         0.0039          aspartate ammonia-lyase                                                                     aspA              [P0AC38](P0AC38)
  −1.53                                              3125         0.0028          PTS system mannose-specific EIIAB component                                                 manX              [P69797](P69797)
  −1.53                                              2041         0.0014          Bifunctional purine biosynthesis protein PurH                                               purH              [P15639](P15639)
  −1.53                                              3125         0.0028          L-threonine dehydratase catabolic TdcB                                                      tdcB              [P0AGF6](P0AGF6)
  −1.51                                              2562         0.0061          Thymidine phosphorylase                                                                     deoA              [P07650](P07650)
  −1.39                                              3005         0.0041          Aspartate--ammonia ligase                                                                   asnA              [P00963](P00963)
  −1.30                                              1408         0.0029          Catalase-peroxidase                                                                         katG              [P13029](P13029)
  −1.30                                              2055         0.0057          3-octaprenyl-4-hydroxybenzoate carboxy-lyase                                                ubiD              [P0AAB4](P0AAB4)
  −1.30                                              2055         0.0057          Malate synthase A                                                                           aceB              [P08997](P08997)
  −1.26                                              3070         0.0094          UDP-glucose 4-epimerase                                                                     galE              [P09147](P09147)
  −1.25                                              2348         0.00189         Glycerol kinase                                                                             glpK              [P0A6F3](P0A6F3)
  −1.21                                              2467         0.0089          Bifunctional protein FolC                                                                   folC              [P08192](P08192)
  −1.15                                              3787         0.0027          2,3-bisphosphoglycerate-dependent phosphoglycerate mutase                                   gpmA              [P62707](P62707)
  +1.09                                              2400         0.0063          Glutamate decarboxylase beta                                                                gadB              [P69910](P69910)
  +1.09                                              2400         0.0063          Bifunctional protein HldE                                                                   hldE              [P76658](P76658)
  −1.52                                              2050         0.00081         Phosphoenolpyruvate carboxykinase                                                           pck               [P22259](P22259)
  −1.40                                              1870         0.0015          Trehalose-6-phosphate hydrolase                                                             treC              [P28904](P28904)
  −1.79                                              3026         0.0012          Galactitol−1-phosphate dehydrogenase                                                        gatD              [P0A9S4](P0A9S4)
  −1.65                                              2131         0.0032          2,3-bisphosphoglycerate-independent phosphoglycerate mutase                                 gpml              [P37689](P37689)
  −1.30                                              2055         0.0057          Phosphoenolpyruvate carboxykinase \[ATP\]                                                   pckA              [P22259](P22259)
  +1.37                                              2105         0.0091          6-phospho-beta-glucosidase A                                                                bglA              [P24240](P24240)
  **GLYCOLYSIS/GLUCONEOGENESIS**                                                                                                                                                                
  −1.65                                              2131         0.0032          2,3-bisphosphoglycerate-independent phosphoglycerate mutase                                 gpml              [P37689](P37689)
  −1.52                                              2050         0.00081         Phosphoenolpyruvate carboxykinase                                                           pck               [P22259](P22259)
  −1.51                                              2562         0.0061          6-phosphogluconate dehydrogenase                                                            gnd               [P00350](P00350)
  −1.48                                              3030         0.0068          Aldehyde reductase, NADPH-dependent                                                         yqhD              [Q46856](Q46856)
  −1.41                                              3078         0.0024          Glyceraldehyde-3-phosphate dehydrogenase A                                                  gapA              [P0A9B2](P0A9B2)
  −1.30                                              1408         0.0029          Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex   aceF              [P06959](P06959)
  −1.21                                              2467         0.0089          D-tagatose−1,6-bisphosphate aldolase subunit GatZ                                           gatZ              [P0C8J8](P0C8J8)
  −1.20                                              3721         0.0024          Deoxyribose-phosphate aldolase                                                              deoC              [P0A6L0](P0A6L0)
  −1.15                                              3787         0.0027          2,3-bisphosphoglycerate-dependent phosphoglycerate mutase                                   gpmA              [P62707](P62707)
  −1.12                                              2062         0.0069          Pyruvate kinase I                                                                           pykF              [P0AD61](P0AD61)
  +1.24                                              2169         0.0053          Phosphoglucomutase                                                                          pgm               [P36938](P36938)
  **AMINOACYL-tRNA BIOSYNTHESIS**                                                                                                                                                               
  −1.69                                              3047         0.0044          Phenylalanine tRNA synthetase, alpha subunit                                                pheS              [P08312](P08312)
  −1.27                                              1307         0.0004          Threonine--tRNA ligase                                                                      thrS              [P0A8M3](P0A8M3)
  −1.19                                              3031         0.0071          tRNA-dihydrouridine synthase A                                                              dusA              [P32695](P32695)
  −1.17                                              2425         0.005           Histidine--tRNA ligase                                                                      hisS              [P60906](P60906)
  +1.20                                              1571         0.0017          Methionine--tRNA ligase                                                                     metG              [P00959](P00959)
  **MICROBIAL METABOLISM IN DIVERSE ENVIRONMENTS**                                                                                                                                              
  −2.76                                              1545         0.0018          Transketolase 2                                                                             tktB              [P33570](P33570)
  −1.85                                              761          0.0062          Formate dehydrogenase, nitrate-inducible, major subunit                                     fdnG              [P24183](P24183)
  −1.56                                              2314         0.0039          Aldehyde dehydrogenase A, NAD-linked                                                        aldA              [P25553](P25553)
  **BIOSYNTHESIS OF SECONDARY METABOLITES**                                                                                                                                                     
  −5.78                                              3272         0.00024         N-acetylneuraminate lyase                                                                   nanA              [P0A6L4](P0A6L4)
  −1.68                                              3674         0.000046        Glucosamine-6-phosphate deaminase                                                           nagB              [P0A760](P0A760)
  −1.72                                              2441         0.0042          Tryptophanase                                                                               tnaA              [P0A853](P0A853)
  −1.30                                              1408         0.0029          Polyribonucleotide nucleotidyltransferase                                                   pnp               [P05055](P05055)
  +1.09                                              2400         0.0063          Glutamate decarboxylase beta                                                                gadB              [P69910](P69910)
  **GLYCEROPHOSPHOLIPID METABOLISM**                                                                                                                                                            
  −1.65                                              2131         0.0032          Aerobic glycerol-3-phosphate dehydrogenase                                                  glpD              [P13035](P13035)
  −1.49                                              1963         0.0055          Anaerobic glycerol-3-phosphate dehydrogenase subunit A                                      glpA              [P0A9C0](P0A9C0)
  **TRANSPORTERS**                                                                                                                                                                              
  −1.67                                              3025         0.0023          Oligopeptide transport ATP-binding protein OppD                                             oppD              [P76027](P76027)
  −1.12                                              2062         0.0069          Ribose import ATP-binding protein RbsA                                                      rbsA              [P04983](P04983)
  +1.37                                              2105         0.0091          Potassium transporter peripheral membrane protein                                           trkA              [P0AGI8](P0AGI8)
  **BACTERIAL CHEMOTAXIS AND MOTILITY?**                                                                                                                                                        
  −1.32                                              3008         0.0066          Flagellar motor switch protein FliM                                                         fliM              [P06974](P06974)
  **OTHER**                                                                                                                                                                                     
  −1.62                                              3317         0.0068          Probable deferrochelatase/peroxidase YfeX                                                   yfeX              [P76536](P76536)
  −1.53                                              2041         0.0014          Ribonuclease G                                                                              rng               [P0A9J0](P0A9J0)
  −1.53                                              2041         0.0014          Transcriptional regulatory protein TyrR                                                     tyrR              [P07604](P07604)
  −1.38                                              3005         0.0041          Uncharacterized oxidoreductase YdgJ                                                         ydgJ              [P77376](P77376)
  −1.32                                              3008         0.0066          Aminomethyltransferase                                                                      gcvT              [P27248](P27248)
  −1.32                                              3206         0.0033          Probable acrylyl-CoA reductase AcuI                                                         acuI              [P26646](P26646)
  −1.30                                              2055         0.0057          Uncharacterized sulfatase YdeN                                                              ydeN              [P77318](P77318)
  −1.26                                              3073         0.0072          HTH-type transcriptional regulator CysB                                                     cysB              [P0A9F3](P0A9F3)
  −1.26                                              979          0.0049          Elongation factor G                                                                         fusA              [P0A6M8](P0A6M8)
  −1.26                                              979          0.0049          Chaperone protein ClpB                                                                      clpB              [P63284](P63284)
  +1.51                                              2148         0.0031          Alkyl hydroperoxide reductase                                                               ahpF              [Q8XBT4](Q8XBT4)
  +1.45                                              2163         0.0077          Alkyl hydroperoxide reductase subunit F                                                     ahpF              [P35340](P35340)
  +1.11                                              1166         0.0056          Outer membrane protein assembly factor BamA                                                 bamA              [P0A940](P0A940)

Biological network and functional annotation analysis
-----------------------------------------------------

The network distributions of the 69 differently expressed proteins were explored using STRING software. The top-ranked networks were in Metabolic Pathways with a *p*-value of 3.45E-10, Glycolysis / Gluconeogenesis (*p* = 5.87E-8) and Microbial metabolism in diverse environments (*p* = 2.11E-7). Stronger associations are represented by thicker lines (Figure [1C](#F1){ref-type="fig"}).

Most of the identified proteins were under expressed with only a few found over expressed. The majority of the down expressed proteins belong to metabolic processes, suggesting a decrease in energy production. However, the most intriguing result in the presence of MMS was the sharp decrease in the expression of the N-acetylneuraminate lyase (NanA) an enzyme involved in sialic acid metabolism. Under methylating stress conditions, NanA expression was reduced by a factor of 2^6^, which corresponds to about 60 times decrease in protein concentration.

Western blot analysis upon methylation stress
---------------------------------------------

Proteomic data were independently confirmed by western blot analysis. Recombinant NanA protein bearing a N-terminal His tag was homologously produced in *E. coli* and purified by metal affinity chromatography. The recombinant protein was characterized by SDS-PAGE and its primary structure verified by MALDI mapping (Figure [1S](#SM1){ref-type="supplementary-material"} of Supplemental Material). Specific anti NanA antibodies were then produced in rabbit, tested using different amounts of *E. coli* extracts and used to assess the expression of NanA under methylation stress conditions.

Figure [2A](#F2){ref-type="fig"} shows the western blot analysis of protein extracts from *E. coli* grown in the absence and in the presence of 0.04% MMS; the corresponding densitometric analysis is shown in Figure [2B](#F2){ref-type="fig"}. Protein content was normalized using the Maltose Binding Protein that was demonstrated to be unaffected by methylation stress by DIGE analysis. A strong decrease in the amount of the lyase was clearly detected upon methylation stress, thus confirming proteomic results.

![**Effect of methylation stress on expression levels of NanA. (A)** Western blot analysis of protein extracts from *E. coli* in the absence and in the presence of 0.04% MMS. **(B)** Densitometric analysis of the immunoblot in **(A)**. Protein content was normalized using the Maltose Binding Protein. Data are expressed as the percentage of relative expression and represent the mean ± SD of three replicates. **(C)** *nanA* gene expression levels measured by real time PCR assays in both MMS treated and untreated *E. coli* cells. Data are expressed as the percentage of relative expression and represent the mean ± SD of three replicates.](fmicb-07-00147-g0002){#F2}

Effect of methylation stress on expression levels of nanA gene, biofilm formation and adhesion capability of non pathogenic *E. coli*
-------------------------------------------------------------------------------------------------------------------------------------

The significant down regulation of NanA was further investigated at mRNA level. Total RNA was extracted from *E. coli* cells either treated or untreated with 0.04% MMS demonstrating a high quality product.

Total RNA was reverse transcribed to obtain cDNA. Real time PCR assays were carried out to detect *nanA* gene expression levels in both MMS treated and untreated *E. coli* cells. Melting point curves displayed a single peak and any amplification of non-specific targets or primer dimers was not observed demonstrating the specificity of amplification. *rpoA* was used as housekeeping gene to normalize the threshold cycle values (Ct). Analyses were performed in triplicate.

The results of PCR amplification are shown in Figure [2C](#F2){ref-type="fig"}. Transcription of *nanA* gene was unaffected by MMS treatment showing a RNA amount almost similar to the untreated cells being the difference shown in Figure [2C](#F2){ref-type="fig"} not significant. Altogether these data suggested the occurrence of a negative translational control of *nanA* exerted by an unknown cellular mechanism in the presence of methylation stress.

Next, we explored the possibility that decreasing NanA levels upon exposure to methylating agents might also affect biofilm formation and adhesion abilities in the non-pathogenic MV1161 *E. coli* strain.

*E. coli* cells were then grown in LB medium supplemented with 1% glucose either in the presence or in the absence of 0.04% MMS. As shown in Figure [3A](#F3){ref-type="fig"}, methylation stress decreased biofilm formation by about 60% compared to non-treated cells.

![**Biofilm formation and adhesion capability of MMS treated non pathogenic *E. coli*. (A)** Biofilm formation of non pathogenic *E. coli* in the presence of MMS. Data are expressed as the percentage of crystal violet absorbance and represent the average of three independent experiments. **(B)** Adhesion capability of non-pathogenic *E. coli* to HeLa cells in the presence and in the absence of MMS. Data represent the average of three independent experiments.](fmicb-07-00147-g0003){#F3}

Since biofilm mechanisms are usually associated to cellular adhesion/invasion processes, we tested the effect of methylation stress on the capabilities of MV1161 to adhere to human HeLa cells. Following 0.04% MMS treatment, *E. coli* cells were subcultured and several different dilutions added to HeLa cells in order to establish the best bacterial/eukaryotic cells ratio. Analyses were performed in triplicate. Data obtained for one of the three cellular dilutions are reported in Figure [3B](#F3){ref-type="fig"} showing that *E. coli* adhesion on HeLa cells was drastically decreased in the presence of 0.04% MMS.

Since NanA expression was heavily decreased following MMS treatment, these data might suggest a possible involvement of this enzyme in the bacterial cohesive properties affecting the biological processes leading to biofilm formation.

Investigation of NanA role in *E. coli* biofilm formation
---------------------------------------------------------

These observations prompted us to further investigate the putative role of NanA in the adhesion properties of *E. coli*. A null NanA mutant was constructed transforming electrocompetent *E. coli* MV1161 strain (Datsenko and Wanner, [@B7]). Biofilm formation experiments were carried out on Δ*nanA* mutant in comparison with MMS treated and untreated MV1161 *E. coli* cells. As reported in Figure [4](#F4){ref-type="fig"}, biofilm formation was drastically reduced in the Δ*nanA* mutant with the effect being very similar to that observed for the MMS treated MV1161 strain.

![**Biofilm formation capability of the Δ*nanA* mutant *E. coli* strain**. Biofilm formation of both wild type and Δ*nanA* mutant *E. coli* strains in the absence and in the presence of 0.04% MMS, and of Δ*nanA* mutant complemented with the *nanA* gene. All data are expressed as percentage of crystal violet absorbance.](fmicb-07-00147-g0004){#F4}

Next we checked the effect of MMS on the residual biofilm formation in the *nanA* mutant strain to investigate whether the observed decrease in the MMS treated cells and in the *nanA* mutant strain are both due to loss of NanA. Biofilm formation experiments were performed on Δ*nanA* mutant under methylation stress conditions in comparison with untreated MV1161 strain as control. Treatment with MMS did not reduce further the biofilm levels in the nanA mutant strain as shown in Figure [4](#F4){ref-type="fig"}, thus indicating that the two effects were not additive.

The biological implication of the lyase in biofilm formation was further supported by complementation assays. The Δ*nanA* mutant was transformed with a plasmid vector harboring a wild type copy of the gene, and the resulting complemented strain was used in biofilm assays as previously described. Figure [4](#F4){ref-type="fig"} shows that biofilm production was greatly increased in the complement strain in comparison to MV1161 wild type strain, demonstrating that re-integration of the lyase NanA fully restored the ability of the mutant strain to adhere to abiotic surface.

The fundamental role of NanA in biofilm formation was finally assessed by performing biofilm experiments in the presence of N-Acetyl-2,3-dehydro-2-deoxyneuraminic acid (DANA). Although DANA is known as a sialidase inhibitor, we hypothesized that, being structurally related to sialic acid, it might also act as a competitive inhibitor of the lyase activity. Biofilm formation was performed in the presence of increasing DANA concentrations ranging from 1 to 100 μg/mL. Figure [5](#F5){ref-type="fig"} shows biofilm production of *E. coli* MV1161 strain in the absence and in the presence of 50 μg/mL DANA inhibitor. From these experiments, we can infer that inhibition of lyase activity greatly affected the biofilm production properties of *E. coli* as demonstrated by the clear decrease in biofilm formation to a level very similar to that observed following MMS incubation.

![**Effect of DANA inhibitor on biofilm formation of MV1161 *E. coli* strain**. Biofilm formation of MV1161 *E. coli* strain in the absence and in the presence of DANA inibitor. Data are expressed as percentage of crystal violet absorbance.](fmicb-07-00147-g0005){#F5}

Effect of methylating agent on adhesion/invasion capabilities of pathogenic *E. coli* LF82 strain
-------------------------------------------------------------------------------------------------

In order to verify if MMS could affect adhesive and invasive properties of a pathogenic *E. coli*, we used the LF82 strain, an adherent-invasive *E. coli* (AIEC) pathogen associated with Crohn\'s disease development (Boudeau et al., [@B2]). This strain showed strong adhesive and invasive capabilities in intestinal cells and prolonged intracellular survival in macrophages, leading to enhanced pro-inflammatory cytokines release (Bringer et al., [@B3]).

As shown in Figure [6A](#F6){ref-type="fig"}, upon addition of 0.04% MMS, LF82 strain showed a decreased steady state level in the growth curve (OD~600LF82~ = 4.7 vs. OD~600LF82+MMS~ = 1.6), a different mid-point (*t*~mid−pointLF82~ = 5.9 h vs. *t*~mid−pointLF82+MMS~ = 3.8 h), and a diminished intrinsic growth rate in the logarithmic phase (*r*~LF82~ = 0.76 vs. r~LF82+MMS~ = 0.37). This result revealed that MMS affected LF82 growth curve, leading to the hypothesis of a parallel alteration in its adhesive and invasive properties.

![**Effect of methylation stress on pathogenic *E. coli* strain LF82 (AIEC)**. **(A)** Growth curves of AIEC strain LF82 in the presence (triangle) and in the absence (circles) of MMS. Superimposed to data points, for each growth curve, is the 4-parameter logistic regression following the formula *y* = *y*~0~ + *a*/\[1+(*x*/*x*~0~)^*b*^\], where *y*~0~ is the intercept with *y*-axis, *a* is the maximum value of *y*, *x*~0~ is the mid-point, and *b* is the curvature coefficient. **(B)** Adhesion indexes of LF82 strain on Caco-2 cells after 4 h infection in the presence and in the absence of MMS. Values are reported as the mean adhesive bacteria (± standard error of the mean) per single Caco-2 cell. **(C)** Invasion indexes of LF82 strain on Caco-2 cells after 4 h infection in the presence and in the absence of MMS. Values are reported as the mean adhesive bacteria (± standard error of the mean) per single Caco-2 cell.](fmicb-07-00147-g0006){#F6}

To asses this point, we performed adhesion and invasion assays upon 4 h of LF82 infection on intestinal Caco-2 cells, a cell line deriving from gut epithelium, the initial target of LF82 adhesion and invasion, in the presence of MMS at concentrations of 0.04%, which did not affect the viability of the pathogenic strain (Figure [6B](#F6){ref-type="fig"}). Results showed that adhesion was diminished by 60.2% (Mann-Whitney, *p* = 0.0238), while invasion by 53.5% (Mann-Whitney, *p* = 0.0353; Figure [6C](#F6){ref-type="fig"}). Interestingly, MMS treatment led also to a diminished aggregative behavior of LF82, which usually aggregates within cell-to-cell junctions on Caco-2 monolayers (data not shown).

Discussion {#s4}
==========

We have pursued a comprehensive investigation at the molecular level on the effect of sub-lethal concentration of MMS in *E. coli*. Using a differential proteomics approach we could establish that short-term exposure to MMS results in a general down regulation of protein expression. However, this effect does not seem to be due to non-specific inhibition of protein synthesis, since not all proteins are affected in the same way. A vast majority of the under expressed proteins belong to glycolysis and fatty acid degradation pathways, strongly suggesting a decrease in energy production. Thus, it might be tempting to speculate that reduction in energy flow, rather than DNA damage, might be responsible for growth inhibition by MMS observed in *E. coli*. Blocking energy generation in response to exposure to MMS might be an adaptive strategy to prevent further rounds of DNA replication, thus limiting DNA damage.

One of the most intriguing results of the proteomic experiment was the large decrease in the expression of the N-acetylneuraminate lyase NanA. This finding was also independently confirmed by western blot analysis using antibodies raised against a recombinant version of the NanA protein. NanA is the first enzyme of the canonical pathway of sialic acid catabolism including *nanA, nanK, nanE, nagA*, and *nagB* and catalyzes the aldolic cleavage of N-acetylneuraminic acid (sialic acid) to form pyruvate and N-acetyl-D-mannosamine (Vimr, [@B20]).

Sialic acid was reported to play a pivotal role in molecular recognition and, particularly in sialidase negative bacteria like *E. coli*, this amino sugar and its metabolites could be a key signal in cell-cell interactions (Sohanpal et al., [@B18]). Indeed, a correlation between sialic acid availability, biofilm formation and invasion of host cells in pathogenic bacteria has already been reported (Trappetti et al., [@B19]).

These observations prompted us to further investigate whether the decrease in NanA expression might also affect cellular adhesive properties and possibly the infection mechanism in commensal and pathogenic strains of *E. coli*. First we examined the transcription of the *nanA* gene in the presence of MMS by RT-PCR experiments showing that methylation stress did not affect mRNA production, suggesting that other unknown mechanisms might be responsible for the low amount of the protein. Experiments on the elucidation of these molecular mechanisms are currently being carried out.

Next we demonstrated that exposure to MMS diminished biofilm formation of about 60% in the MV1161 laboratory strain. Analogously, *E. coli* adhesion to HeLa cells resulted drastically decreased in the presence of MMS, indicating that a correlation exists between methylation stress and cellular adhesive properties. Interestingly, MMS treatment decreased by almost 50% the adhesive properties of LF82, a pathogenic *E. coli* strain associated to Crohn disease, with strong adhesive and invasive capabilities in intestinal cells (Miquel et al., [@B14]).

These results led us to speculate that inhibition of cell adhesion might be related to downregulation of the NanA lyase, in line with the involvement of sialic acid in biofilm formation and adhesion properties. To investigate this point, we produced an *E. coli* mutant strain lacking the *nanA* gene. We only constructed the nanA mutant in the MV1161 background, as attempts to create mutants in the LF82 strain have been so far unsuccessful due to its lower amenability to genetic manipulation. The Δ*nanA* mutant showed a phenotype nearly superimposable to the control MV1161 *E. coli* under methylation stress conditions. Moreover, no further reduction in biofilm formation was detected when the Δ*nanA* mutant was treated with MMS, suggesting that impairment of cell-cell interactions by methylation stress is only related to the lyase biological activity.

This hypothesis was further supported by both complementation assays and using a competitive synthetic inhibitor. Re-integration of the *nanA* gene within the Δ*nanA* strain resulted in the rescue of bacterial phenotype completely restoring the ability of the mutant strain to produce biofilm. Adhesion/invasion assays on both the mutant and the complemented strain were not performed since both strains derived from the MV1161 non pathogenic *E. coli* species devoted of invasion abilities Finally, in the presence of the DANA inhibitor, biofilm formation was greatly diminished in MV1161 *E. coli* strain decreasing to a level very similar to that observed under methylation stress conditions.

Sialic acid is widely recognized as a signaling molecule playing a role in the mechanism of biofilm formation, colonization and host invasion at different extent (Sohanpal et al., [@B18]; Trappetti et al., [@B19]). Nontypeable *H. influenzae* (NTHI) produces a lipooligosaccharide decorated with sialic acid due to the activity of a number of genes responsible for carbohydrate biosynthesis and assembly (Greiner et al., [@B9]). A causal association between sialic acid and pneumococcal biofilm formation *in vitro* was also demonstrated supporting the hypothesis that free sialic acid is a trigger that converts a harmless colonizing pneumococcus into an invasive pathogen. Finally, sialic acid and its metabolites GlcNAc and GlcNAc-6-P were also found involved in regulatory mechanisms affecting *E. coli* type I fimbriae expression, structure required for bacterial adhesion to host cells (Sohanpal et al., [@B18]).

These results confirmed the hypothesis that impairment of biofilm formation under methylation stress involves downexpression of NanA and underlined the importance of sialic acid metabolism to promote/prevent cell-cell interactions.
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**Purification of His Tagged NanA protein. (A)** Nickel Affinity chromatography of the *E. coli* expressed His-tagged NanA protein. **(B)** SDS-PAGE analysis of the purified recombinant NanA protein. Lane 1: total *E. coli* protein extrcts; lane 3: unbound proteins: lane 9--14: Nickel Affinity chromatography fractions eluted with 500 mM imidazole.
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